Welcome to the PharmaCamp with Neha. This is a small initiative from my side to share knowledge about the pharmaceutical world and regulatory, as I feel education is the best gift one can receive or give back to society.
Are you a working professional who wants to upgrade your skills? OR a student who wants to make a career in pharmaceuticals? OR are you a person who is interested to learn about the regulatory systems? Then this YouTube channel is for you.
About me:
I am Neha Parashar, working as a Associate Director in a pharmaceutical company and based in Germany. I am a passionate healthcare professional, an educator, and a mentor.
In this series 'Orphan Drug Development', I will discuss the regulatory aspects related to orphan drugs.
Channel Introduction- Welcome to PharmaCamp [ Ссылка ]
Series 1 -Regulatory Learnings | Investigational New Drug (IND) Application
[ Ссылка ]
Series 2-Regulatory Shorts
[ Ссылка ]
Series 3-EU Marketing Authorisation
[ Ссылка ]
Series 4-Dare to Lead with Neha | An Interview Series with Pharma Leaders
[ Ссылка ]
Series 5-Orphan Drug Development
[ Ссылка ]__
LinkedIn: [ Ссылка ]
LinkedIn Articles on various Regulatory Topics:
1. Regulatory Pathways for Expedited Access of Medicines [ Ссылка ]...
2. Step-wise Regulatory approach for the Paediatric drug Development [ Ссылка ]...
3. Designing the Global Regulatory Strategy for the Development of Orphan Medicinal Products
[ Ссылка ]...
4. Step wise approach for Quality Risk Management (QRM) in pharmaceutical industries [ Ссылка ]...
5. Step-wise regulatory approach for the assessment of process related impurities in biological products [ Ссылка ]...
6. Step-wise approach for sterilisation package preparation in regulatory dossiers for biologicals and other liquid sterilised products [ Ссылка ]...
7. Step-wise approach for regulatory risk assessment of adventitious agents in biologicals products [ Ссылка ]...
8. Five Step Approach to Assess Equivalency Requirements of Topical Products [ Ссылка ]...
Disclaimer- This video channel is for educational purposes. These are purely my views and not any recommendations. The channel does not represent the views of the organization I am associated with, and it has no connection with my current organization.
